Purchase Order HT001422P0040
Award Date 1/28/22
Potential Completion Date 2/10/22
Potential Value $339K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Health Agency (DOD) awarded a $745,185 purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for APTIMA SARS-COV-2 ASSAY KITS. The firm fixed price contract will provide coronavirus COVID-19 testing kits to support national interest actions in Japan, with performance taking place from May 10, 2022 through June 1, 2022.</p>
- The Defense Health Agency awarded a $380,520 firm fixed price delivery order contract to Gen-Probe Incorporated on March 24, 2021 to supply COVID-19 reagents. The contract has an anticipated completion date of April 1, 2021 and supports the agency's efforts responding to the Coronavirus Disease 2019 pandemic under the National Interest Action Code for COVID-19. Gen-Probe Sales & Service, Inc. will perform the contract from their place of performance in Marlborough, Massachusetts. No...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract is for the delivery of APTIMA SARS-CoV-2 tests to detect COVID-19, with a potential value of $745,185.00 and a completion date of March 31, 2023. The contract is part of the agency's efforts to procure necessary medical supplies related to the Coronavirus COVID-19 national interest...
- The Defense Health Agency awarded a $2,300 firm fixed price delivery order contract to Gen-Probe Incorporated for COVID19 reagents. The contract has no set aside designation and requires performance in Marlborough, Massachusetts by March 23, 2021. Gen-Probe Sales & Service, Inc. will perform as a division of Gen-Probe Incorporated. The contract was awarded on March 16, 2021 under the National Interest Action Code for Coronavirus COVID-19 in support of the Defense Health Agency's response...
- The Defense Health Agency awarded a $745,185 firm fixed price purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. for 94 Aptima SARS-CoV-2 assay boxes containing 250 tests per box, 47 Aptima SARS-CoV-2 control boxes with five positive and five negative controls per box, and 235 Fusion specimen lysis tubes in 100 bags per box. The place of performance is in Marlborough, Massachusetts and the period of performance runs from February 17, 2022 through September 30, 2023....
- The Defense Health Agency (DOD) awarded a $888,380 firm fixed price delivery order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. for COVID19 reagents. The contract has a period of performance from November 17, 2020 through March 12, 2021, with all work to be conducted by the prime contractor at its location in Marlborough, Massachusetts. This delivery order is likely associated with DHA's medical products procurement programs to support the COVID-19 response effort. No...
- This firm fixed-price purchase order was awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of 250 APTIMA SARS-CoV-2 assay test kits, 30 APTIMA SARS-CoV-2 controls, and 76 Fusion specimen lysis tubes. The total potential value of the award is $239,790.00. The purchase order was not set aside and supports the government's Coronavirus COVID-19 response efforts. Gen-Probe Incorporated is a provider of molecular diagnostic testing...
- This is a $158,550.00 Firm Fixed Price Delivery Order contract awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company. The contract is for the provision of COVID-19 assays, with an ultimate completion date of January 15, 2021. Gen-Probe is a prime contractor that has held numerous contracts with defense and civilian agencies, primarily supplying testing kits, reagents, and equipment for detecting infectious diseases. This award is not associated...
- This is a $249,560.00 firm fixed-price purchase order contract awarded by the Defense Health Agency to Gen-Probe Incorporated for the APTIMA SARS-COV-2 ASSAY. The contract has a completion date of May 12, 2022 and was awarded on February 11, 2022. Gen-Probe is a medical diagnostics company that specializes in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal government. The company has held numerous contracts with defense and civilian agencies...
- This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company, for the provision of COVID-19 reagents. The contract, which does not have a set-aside designation, has a ceiling value of $399,410.00 and a period of performance through September 30, 2021. Gen-Probe, which specializes in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal government, has held numerous...